Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison

CONTEXT: OnabotulinumtoxinA and mirabegron have recently gained marketing authorisation to treat symptoms of overactive bladder (OAB). OBJECTIVE: To evaluate the relative efficacy of mirabegron and onabotulinumtoxinA in patients with idiopathic OAB. DESIGN: Network meta-analysis. DATA SOURCES: A sea...

Descripción completa

Detalles Bibliográficos
Autores principales: Freemantle, Nick, Ginsberg, David A, McCool, Rachael, Fleetwood, Kelly, Arber, Mick, Khalaf, Kristin, Loveman, Clara, Ni, Quanhong, Glanville, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769403/
https://www.ncbi.nlm.nih.gov/pubmed/26908514
http://dx.doi.org/10.1136/bmjopen-2015-009122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769403/
https://www.ncbi.nlm.nih.gov/pubmed/26908514
http://dx.doi.org/10.1136/bmjopen-2015-009122

Ejemplares similares